Skip to main content

JANE STREET GROUP, LLC

Position in VTGN — Vistagen Therapeutics, Inc.

CIK 1595888 NEW YORK, NY

Position in VTGN

as of Mar 31, 2026 · filed May 12, 2026
Position Value
$155,500
-$192,402 QoQ
Shares Held
272,811
-48.2% QoQ
Ownership
0.665%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2023
6 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VTGN Over Time

Shares Held

Position Value (USD)

Derivatives in VTGN

reported options exposure · as of Mar 31, 2026
CallValue
$13,224
CallShares
23,200
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

JANE STREET GROUP, LLC holds $1,248,975,671 across 317 Biotechnology names. VTGN ranks #235 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in VTGN

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $155,500 272,811
2026-03-31 $13,224 23,200
2025-12-31 $52,602 79,700
2025-12-31 $347,902 527,127
2025-09-30 $1,074,524 302,683
2025-09-30 $51,475 14,500
2025-06-30 $190,102 95,051
2024-09-30 $59,172 19,659
2023-12-31 $112,771 21,940